CD8A and neoplasm: This process is similar to a vaccine, but it occurs within tumor tissues and ultimately induces the killing effect of CD8 T cells, effectively preventing tumor recurrence and metastasis (Figure 5D; Macleod et al., 2014; Eissa et al., 2021; Yamashita et al., 2021).